Response to COVID-19 Public Health Emergency

District of ColumbiaAgency guidance

Ask Donna

How this section applies to your facts.

DC DISB Insurance Bulletins and Notices › Response to COVID-19 Public Health Emergency

This text was captured on Aug 14, 2026. It is a snapshot, not a live feed, so check the official code before relying on it.

Text

Government of the District of Columbia

Department of Insurance, Securities and Banking

1050 First Street, NE, Suite 801  Washington, DC 20002  Tel: 202-727-8000  disb.dc.gov

Karima Woods

Acting Commissioner

Commissioner’s Order 01-2020

RESPONSE TO COVID-19 PUBLIC HEALTH EMERGENCY

WHEREAS, on March 11, 2020, Mayor Muriel Bowser declared a Public Emergency and Public

Health Emergency pursuant to Mayor’s Order 2020-046, as supplemented by the COVID-19

Response Emergency Amendment Act of 2020, effective March 17, 2020 (D.C. Act 23-0247; ___

DCR___) (“Act”), because of the impact of COVID-19 in the District;

WHEREAS, pursuant to D.C. Official Code §§ 7-2304(b) and 7-2304.01(d), Mayor Bowser has

authorized and directed the Commissioner of Insurance, Securities and Banking to exercise the

emergency powers conferred by § 302 of the Act as are necessary to protect the interests of health

carriers, enrollees and the public for the duration of the public health emergency;

THEREFORE, pursuant to § 302 of the Act, it is hereby ORDERED, effective immediately, that

the following emergency measures shall be implemented and remain in effect through the duration

of the Public Health Emergency, including any extensions, and shall apply to all carriers offering

health benefit plans in the District as defined at D.C. Official Code § 31-3301.01(20) and all

medical services obtained during such period:

1

e Act, it is hereby ORDERED, effective immediately, that

the following emergency measures shall be implemented and remain in effect through the duration

of the Public Health Emergency, including any extensions, and shall apply to all carriers offering

health benefit plans in the District as defined at D.C. Official Code § 31-3301.01(20) and all

medical services obtained during such period:

1. Screening, testing and treatment: To ensure that cost does not create a barrier for

consumers receiving medically necessary screening, testing and treatment for COVID-19

or suspected COVID-19 or respiratory diseases and illnesses detected in the course of

seeking screening, testing, or treatment for COVID-19 when a provider recommends such

services pursuant to Centers for Disease Control (“CDC”) guidelines, all carriers shall

make these services available with no deductible, coinsurance, copayment, or other costsharing of any kind, including all associated costs such as processing fees and clinical

evaluations, and shall not require prior authorization. While enrollees may be encouraged

to visit their primary care practitioners or other network providers for screening, testing

and treatment, carriers shall cover all out-of-network charges including cost-sharing and

balance billing unless the enrollee was first offered the service in-network without

unreasonable delay. The Department will be instituting expedited grievance procedures to

review adverse decisions on requests for coverage for COVID-19 related health services.

2. Network adequacy: Out-of-network providers and facilities are requested to accept the

highest of a carrier’s in-network reimbursement as full and final payment and to hold

harmless enrollees who receive health care services as it relates to screening, testing and

treatment of COVID-19. Providers are also encouraged to use the enrollee’s in-network

coverage for COVID-19 related health services.

2. Network adequacy: Out-of-network providers and facilities are requested to accept the

highest of a carrier’s in-network reimbursement as full and final payment and to hold

harmless enrollees who receive health care services as it relates to screening, testing and

treatment of COVID-19. Providers are also encouraged to use the enrollee’s in-network

2

laboratory facilities. Charges by out-of-network providers will be subject to the prohibition

on overcharging during a public health emergency pursuant to D.C. Official Code 28-4102.

3. Immunizations and vaccines: If and when an immunization or vaccine becomes available

for COVID-19 per CDC guidelines, carriers shall immediately cover the cost for such

services, including all associated costs of administration without cost-sharing.

4. Emergency care: Carriers are reminded that District law requires coverage of emergency

services, with network-level cost-sharing regardless of the status of the emergency

provider, whenever a prudent layperson, possessing an average knowledge of medicine and

health, would believe that immediate medical attention is necessary to avoid serious

jeopardy to health, serious impairment of a bodily function; or serious dysfunction of any

organ or body part. Prior authorization may not be required for emergency services.

5. Telehealth: Because COVID-19 is a communicable disease, some enrollees might choose

or be asked to use telehealth services instead of in-person health care services, or might be

under restrictions that limit their ability to visit providers in person. Carriers shall enhance

their coverage of telehealth services, and are directed to review their telehealth programs

with participating providers to ensure that the programs are robust and will be able to cover

any increased demand. Cost sharing for telehealth services shall not be more than for inperson services.

6

might be

under restrictions that limit their ability to visit providers in person. Carriers shall enhance

their coverage of telehealth services, and are directed to review their telehealth programs

with participating providers to ensure that the programs are robust and will be able to cover

any increased demand. Cost sharing for telehealth services shall not be more than for inperson services.

6. Access to prescription drugs: If supply chain disruptions result in shortages of medications

that are on a carrier’s formulary, the carrier must act promptly to make substitutes available

when necessary, at no greater cost to the patient and without imposing prior authorization

or step therapy requirements. Carriers shall also allow enrollees to obtain refills of their

prescription medications before the scheduled refill date, so that enrollees are assured of

maintaining an adequate supply. Exceptions may be made for drug classes subject to

misuse, such as opioids, benzodiazepines, and stimulants. Carriers shall also waive any

additional cost to the enrollee of any fees associated with accessing prescriptions from a

mail-order pharmacy.

7. Utilization review: When dealing with limited resources or unusual demand for health care

services, carriers must prioritize the timely delivery of medically necessary services to

enrollees. Both for services related to COVID-19 and any other care that their enrollees

might need, carriers must conduct any applicable utilization review and appeal processes

as expeditiously as possible.

8. Communication: Timely access to accurate information and avoiding misinformation are

critical. Carriers shall give prompt notice to enrollees, providers, and the public of the

measures they are taking to respond to the COVID-19 threat, including measures taken to

comply with the terms of this order. Carriers shall ensure that the information shared is

updated on an ongoing basis to remain current and accurate

Timely access to accurate information and avoiding misinformation are

critical. Carriers shall give prompt notice to enrollees, providers, and the public of the

measures they are taking to respond to the COVID-19 threat, including measures taken to

comply with the terms of this order. Carriers shall ensure that the information shared is

updated on an ongoing basis to remain current and accurate. Carriers must provide clear

and prominent notice that they are waiving cost-sharing for medically necessary screening,

testing and treatment for COVID-19, include links to DC Health’s website and guidance

in their communications and on their website, and that early prescription refills are

3

permitted. This notice must be posted prominently on the carrier’s website, provided to all

customer service personnel and all nurse help-lines and similar programs, and delivered to

all network providers and facilities. Carriers shall provide the Commissioner with copies

of all notices.

9. Terminations: Carriers shall not cancel or non-renew any health benefit plan without

express consent from the Commissioner.

Date: March 20, 2020.

_____________________________________

Karima Woods

Acting Commissioner

Department of Insurance, Securities and Banking

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.